Ignite Creation Date:
2024-05-06 @ 9:52 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03093116
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2017-03-06
Brief Title:
A Study of Repotrectinib TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK ROS1 or NTRK1-3 Rearrangements
Sponsor:
Turning Point Therapeutics Inc
Organization:
Turning Point Therapeutics Inc
Organization Data
Organization:
Turning Point Therapeutics Inc
Class:
INDUSTRY
Study ID:
CA127-1024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Turning Point Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Zai Lab Shanghai Co Ltd | INDUSTRY |